文献速递心外重症与机械循环支持

心脏移植前临时机械循环支持的发生率及其对移植后结局的影响

Incidence of temporary mechanical circulatory support before heart transplantation and impact on post-transplant outcomes.
PubMed 文献 · J Heart Lung Transplant · 2018-04-26

基于1998至2014年美国全国住院患者样本中6892例原位心脏移植患者,456例(6.6%)移植前接受临时机械循环支持(tMCS)。tMCS使用量从1998至2002年每年17例增至2012至2014年每年40例(趋势p<0.001)。2007年后移植后住院死亡率在是否使用tMCS者间无显著差异(4.7% vs 5.1%,p=0.9),但tMCS组并发症更多。

要点

  • 移植前tMCS使用从每年17例增至每年40例(趋势p<0.001)。
  • 2007至2014年住院死亡率tMCS组4.7% vs 无tMCS组5.1%,无显著差异(p=0.9)。
  • tMCS组住院时间延长,急性肾、肝、呼吸衰竭、脓毒症、出血及再手术率升高。

核心结论

  • 心脏移植前tMCS使用增加;近期(2007至2014年)移植后住院死亡率在是否使用tMCS者间无差异,但tMCS者并发症率升高。
  • 这些数据支持在适当选择的患者中移植前使用tMCS。
  • 鉴于美国器官共享联合网络(UNOS)心脏分配方案即将变更,临床医生在决定植入tMCS时应权衡上述结局。

研究设计与样本

  • 使用1998至2014年美国全国住院患者样本(National Inpatient Sample),识别6892例接受原位心脏移植的患者,按移植前ECMO、PVAD、IABP或无移植前tMCS分类,比较基线与住院结局。

主要发现

  • 456例(6.6%)心脏移植患者移植前接受tMCS。
  • tMCS使用从1998至2002年每年17例增至2012至2014年每年40例(趋势p<0.001)。
  • tMCS患者中IABP 341例(74.8%)、ECMO 130例(28.5%)、PVAD 21例(4.6%)。
  • 2007年前tMCS者住院死亡率高于无tMCS者(14.3% vs 7.5%,p=0.05);2007至2014年死亡率无显著差异(4.7% vs 5.1%,p=0.9)。
  • 所有患者住院死亡率随时间改善,tMCS者改善最明显(绝对风险降低9.6%);但tMCS者住院时间延长,急性肾、肝、呼吸衰竭、脓毒症、出血并发症及外科再手术率升高。

临床怎么用

  • 作者认为这些数据支持在适当选择的患者中移植前使用tMCS。
  • 作者提出临床医生在决定植入tMCS时应权衡上述结局,背景为UNOS心脏分配方案即将变更。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proposed changes to the United Network for Organ Sharing heart transplant allocation protocol will prioritize patients receiving temporary mechanical circulatory support (tMCS), including extracorporeal membrane oxygenation (ECMO), percutaneous ventricular assist devices (PVADs), and intra-aortic balloon pumps (IABPs). We sought to evaluate contemporary trends in the incidence and outcomes of patients who required tMCS during the hospitalization before heart transplantation. METHODS: Using the National Inpatient Sample from 1998 to 2014, we identified 6,892 patients who received an orthotopic heart transplant and classified them by pre-transplant ECMO, PVAD, or IABP placement or no pre-transplant tMCS. We compared baseline characteristics and in-hospital outcomes between patients who underwent pre-transplant ECMO, PVAD, or IABP and patients who did not receive tMCS before heart transplantation. RESULTS: Of patients who underwent heart transplantation, 456 (6.6%) received tMCS before transplant. During the study period, the use of tMCS more than doubled, from 17 cases per year from 1998 to 2002 to 40 cases per year from 2012 to 2014 (p < 0.001 for trend). Of patients with tMCS, 341 (74.8%) were supported by IABP, 130 (28.5%) were supported by ECMO, and 21 (4.6%) were supported by PVAD. Before 2007, patients who required tMCS had higher in-hospital mortality than patients who did not require tMCS before transplant (14.3% vs 7.5%, p = 0.05). In the subsequent era (2007 to 2014), mortality was not significantly different (4.7% vs 5.1%, p = 0.9). Hospital mortality improved over time for all patients but most significantly in patients who required tMCS (9.6% absolute risk reduction). However, patients who received tMCS had increased lengths of stays and rates of acute renal, hepatic, and respiratory failure, sepsis, bleeding complications, and surgical reoperations. CONCLUSIONS: The use of tMCS before cardiac transplantation is increasing, with no difference in in-patient post-transplant mortality in the recent era between patients who did and did not receive tMCS but with increased complication rates among those who received tMCS. These data support the use of tMCS before cardiac transplantation in appropriately selected patients. Clinicians should balance the above outcomes when making decisions to implant tMCS, given the impending changes to the United Network for Organ Sharing heart allocation protocol.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Ouyang D, Gulati G, Ha R, et al. Incidence of temporary mechanical circulatory support before heart transplantation and impact on post-transplant outcomes. J Heart Lung Transplant. 2018. PMID: 29907499. doi:10.1016/j.healun.2018.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。